APR Applied Pharma Research SA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:APR Applied Pharma Research SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3039
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
APR Applied Pharma Research SA (APR) is a healthcare product developer and distributor. The company research, develops, and licenses technology and clinically proven prescription pharmaceuticals. It offers consumer health products, prescription healthcare products and therapeutic products. APR’s product pipeline portfolio includes nexodyn, gemiax, exelya, APR 1301-01, APR 1203-01 and APR 1204. The company offers services such as oral formulations, tropical formulations and analytical services. It develops products for various therapeutic areas including cancer, dermatology, genetic metabolic diseases, pain management and tissue transplantation APR is headquartered in Balerna, Switzerland.

APR Applied Pharma Research SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
APR Applied Pharma Research SA, Medical Devices Deals, 2012 to YTD 2018 9
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
APR Applied Pharma Research Raises Funds through Venture Financing 11
Private Equity 12
HBM Partners Acquires Minority Stake in APR Applied Pharma 12
Partnerships 13
APR Applied Pharma Research Enter into Distribution Agreement with Aghraas-Cigalah 13
Fidia Farmaceutici Enters into Agreement with APR Applied Pharma Research 14
Licensing Agreements 15
Mundipharma Enters into Licensing Agreement with APR Applied Pharma Research 15
Renhe Enters into Licensing Agreement with APR Applied Pharma Research for Diclofenac Powder 16
APR Applied Pharma Research And Labtec Enter Into Licensing Agreement With Norgine For Setofilm 17
Eris Pharma Enters into Licensing Agreement with APR Applied Pharma Research 18
APR Applied Pharma Enters into Licensing Agreement with Amicus 19
Angelini Enters Into Licensing Agreement With APR Applied Pharma 20
APR Applied Pharma Research SA – Key Competitors 21
APR Applied Pharma Research SA – Key Employees 22
APR Applied Pharma Research SA – Locations And Subsidiaries 23
Head Office 23
Recent Developments 24
Product News 24
Sep 05, 2017: PKU: Pre-Clinical Kinetic Data Showing Prolonged Release of Amino Acids Thanks to the Innovative Physiomimic Technology by APR Presented at the 13th ICIEM Congress (September 5th-8th, Rio de Janeiro) 24
Apr 06, 2017: APR Applied Pharma Research Wants to Make the Difference for PKU People Thanks to an Innovative and Patented Technology 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Key Facts 2
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
APR Applied Pharma Research SA, Deals By Therapy Area, 2012 to YTD 2018 8
APR Applied Pharma Research SA, Medical Devices Deals, 2012 to YTD 2018 9
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
APR Applied Pharma Research Raises Funds through Venture Financing 11
HBM Partners Acquires Minority Stake in APR Applied Pharma 12
APR Applied Pharma Research Enter into Distribution Agreement with Aghraas-Cigalah 13
Fidia Farmaceutici Enters into Agreement with APR Applied Pharma Research 14
Mundipharma Enters into Licensing Agreement with APR Applied Pharma Research 15
Renhe Enters into Licensing Agreement with APR Applied Pharma Research for Diclofenac Powder 16
APR Applied Pharma Research And Labtec Enter Into Licensing Agreement With Norgine For Setofilm 17
Eris Pharma Enters into Licensing Agreement with APR Applied Pharma Research 18
APR Applied Pharma Enters into Licensing Agreement with Amicus 19
Angelini Enters Into Licensing Agreement With APR Applied Pharma 20
APR Applied Pharma Research SA, Key Competitors 21
APR Applied Pharma Research SA, Key Employees 22

List of Figures
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
APR Applied Pharma Research SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
APR Applied Pharma Research SA, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[APR Applied Pharma Research SA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AnaptysBio Inc:企業のM&A・事業提携・投資動向
    AnaptysBio Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's AnaptysBio Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Arcam AB:企業の戦略的SWOT分析
    Arcam AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Calypso Biotech SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Calypso Biotech SA (Calypso) is a biopharmaceutical company that develops antibody therapies. The company provides pipeline products such as CALY-0001 and CALY-0002. Its CALY-0001 therapeutic antibody is used in the treatment of Crohn’s disease; and CALY-0002 a humanized monoclonal antibody …
  • Nuclear Decommissioning Authority:企業の戦略的SWOT分析
    Nuclear Decommissioning Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • NIIT Ltd (NIITLTD):企業の財務・戦略的SWOT分析
    NIIT Ltd (NIITLTD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Orsted Salg & Service AS:企業の戦略的SWOT分析
    Orsted Salg & Service AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Hitachi Koki Co., Ltd.:企業の戦略的SWOT分析
    Hitachi Koki Co., Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • DreamWorks Animation LLC:企業の戦略的SWOT分析
    DreamWorks Animation LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Taisho Pharmaceutical Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Taisho Pharmaceutical Co Ltd (Taisho), a subsidiary of Taisho Pharmaceutical Holdings Co Ltd is a pharmaceutical company that develops, manufactures and markets a range of prescription pharmaceutical and self-medication drugs. The company offers products that include lipovitan D, riup, clari …
  • Aviakompaniya Sibir” OAO (P):企業の戦略・SWOT・財務分析
    Aviakompaniya Sibir'' OAO (P) - Strategy, SWOT and Corporate Finance Report Summary Aviakompaniya Sibir'' OAO (P) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Ensign Energy Services Inc (ESI):企業の財務・戦略的SWOT分析
    Summary Ensign Energy Services Inc (Ensign Energy) is an oil and gas company that offers oilfield services. The company’s services include directional drilling, horizontal drilling, well servicing and testing services. It provides well completions and recompletions, abandonment of redundant wells, s …
  • Dassault Systemes SA:企業の戦略・SWOT・財務情報
    Dassault Systemes SA - Strategy, SWOT and Corporate Finance Report Summary Dassault Systemes SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Probiogen AG-製薬・医療分野:企業M&A・提携分析
    Summary Probiogen AG (Probiogen), a subsidiary of Minapharm Pharmaceuticals & Chemical Industries is a contract development and manufacturing organization that offers cell line engineering, process development and GMP manufacturing of biopharmaceuticals. The organization’s services comprise therapeu …
  • Ahn-Gook Pharmaceutical Co Ltd (001540)-製薬・医療分野:企業M&A・提携分析
    Summary Ahn-Gook Pharmaceutical Co Ltd (Ahn-Gook Pharmaceutical) is a developer and supplier of medicines. The company provides health functional food, medical device, ethical drug, over the counter drugs, and others. Its products include acefenac tab, ahngook carvedilol tab, ahngook cefaclor cap, a …
  • Itau Unibanco Holding SA:企業の戦略・SWOT・財務情報
    Itau Unibanco Holding SA - Strategy, SWOT and Corporate Finance Report Summary Itau Unibanco Holding SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Independence Group NL:企業のM&A・事業提携・投資動向
    Independence Group NL - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Independence Group NL Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Simon Property Group Inc (SPG):企業の財務・戦略的SWOT分析
    Simon Property Group Inc (SPG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Surge Energy Inc (SGY):企業の財務・戦略的SWOT分析
    Summary Surge Energy Inc (Surge) is an oil and gas company that offers acquisitions, exploration and production of crude oil and natural gas reserves. The company provides risk management and risk development drilling services. Its oil and natural gas producing properties include Shaunavon and Dodsl …
  • United States Steel Corp (X):企業の財務・戦略的SWOT分析
    United States Steel Corp (X) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Alkermes Plc (ALKS):企業の財務・戦略的SWOT分析
    Alkermes Plc (ALKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆